Michelle LeRoux Williams
Chief Tech/Sci/R&D Officer chez ELUTIA INC.
Fortune : - $ au 31/03/2024
Profil
Michelle LeRoux Williams is currently a member of the American Institute for Medical & Biological Engineering and the Chief Scientific Officer at Elutia, Inc. She was previously the Chief Scientific Officer at Osiris Therapeutics, Inc. from 2009 to 2014.
Dr. Williams holds a doctorate degree from Duke University and an undergraduate degree from Rice University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ELUTIA INC CLASS A
-.--% | 11/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Michelle LeRoux Williams
Sociétés | Poste | Début |
---|---|---|
ELUTIA INC. | Chief Tech/Sci/R&D Officer | 26/08/2022 |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Corporate Officer/Principal | - |
Anciens postes connus de Michelle LeRoux Williams
Sociétés | Poste | Fin |
---|---|---|
OSIRIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15/04/2014 |
Formation de Michelle LeRoux Williams
Duke University | Doctorate Degree |
Rice University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELUTIA INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Commercial Services |